Products

OncoAI Suite (BrainTumor AI)
Carina AI
Oncology AI
OncoAI Suite is an AI-native oncology imaging suite for cancer detection, segmentation, measurement, and longitudinal tracking across CT, MRI, and PET/CT. The BrainTumor AI module is currently in clinical use, providing volumetric tracking for glioma, brain metastasis, and vestibular schwannoma.

See all 1 product →

About Carina AI

Carina AI is an innovative healthcare artificial intelligence company focused on enhancing clinical workflows and improving patient outcomes through advanced AI solutions. Their platform is designed to integrate seamlessly into existing healthcare systems, providing physicians with tools that streamline administrative tasks, optimize diagnostic processes, and personalize treatment plans. By leveraging machine learning and natural language processing, Carina AI aims to reduce physician burnout by automating repetitive tasks, allowing clinicians to dedicate more time to direct patient care.

The company’s technology is particularly relevant for physicians seeking to improve efficiency and accuracy in their practice. Carina AI’s solutions can assist in areas such as medical imaging analysis, predictive analytics for disease progression, and intelligent documentation support. Their goal is to empower healthcare providers with actionable insights derived from complex medical data, ultimately leading to more informed decision-making and a higher quality of care for patients. They emphasize data security and compliance with healthcare regulations, ensuring that patient information is handled with the utmost privacy and integrity.

Focus Areas

Medical imaging AI clinical research data curation radiation oncology auto-contouring dose verification de-identification multimodal data processing

Business Intelligence

TechnologyOn-premise, AI-Native Multimodal Data Curation Platform (CuratAI), local LLM for structured data extraction

What Physicians Need to Know

Medical Imaging AI & Radiation Oncology
Carina AI offers FDA 510(k)-cleared products like INTContour for AI-native auto-contouring (120+ OARs across CT, MRI, PET/CT) and INTDose for independent Monte Carlo 3D secondary dose verification. They also have NIH-supported research tools like OncoAI Suite for oncology imaging (detection, segmentation, tracking of LymphNode, BrainTumor, LungNodule across CT, MRI, PET/CT) and QuantBrain for brain quantification. Their auto-contouring can be customized by clinics to train on their own data.
Clinical Research Data Curation
CuratAI is Carina AI's on-premise, AI-native multimodal data curation platform for clinical research. It handles multi-source retrieval from PACS, EHR, and pathology systems, ingests unstructured data into structured formats using local LLMs, and performs comprehensive de-identification across five PHI vectors (headers, dates, burned-in pixel text, facial features, clinical reports). It also features AI-assisted annotation and a plugin slot for custom AI models.
De-identification & Privacy
Carina AI specializes in pixel-level de-identification, including mask-based defacing that preserves intracranial anatomy while removing facial features, and semantic text de-identification using on-premise LLMs to strip PHI from notes and reports. Their systems are designed for on-premise execution, ensuring patient data remains within the institutional firewall and no PHI leaves the institution.
Multimodal Data Processing
Their CuratAI platform supports multimodal data, including DICOM, NIfTI, WSI, PDF, and clinical notes, through a single pipeline. It can pull data from various sources like PACS, EHR, pathology systems, REDCap, Excel, or CSV exports.
Physician Tip

For physicians, Carina AI's solutions offer enhanced efficiency and accuracy in radiation oncology treatment planning through FDA-cleared auto-contouring (INTContour) and independent dose verification (INTDose). The ability to train custom AI models on local institutional data with INTContour means the AI can adapt to specific clinical protocols, potentially leading to more accurate contours than generic vendor models. For researchers, CuratAI streamlines the often time-consuming process of data curation and de-identification, allowing for faster preparation of research-ready cohorts while maintaining strict privacy standards. The on-premise architecture ensures data security and compliance, a critical factor for sensitive patient information. The AI-assisted annotation can significantly reduce the manual effort in research pipelines. Additionally, the OncoAI Suite and QuantBrain offer advanced AI tools for cancer imaging and brain quantification in research settings, with some components already in clinical use or on the FDA pathway.

Carina AI's INTContour integrates with Treatment Planning Systems (TPS) like Varian Eclipse and supports automated DICOM workflows. Their CuratAI platform connects to PACS, EHR, and pathology systems for multi-source data retrieval and allows for cross-institution sharing of de-identified projects. The platform is designed to run entirely within an institution's network, including its local LLM, without cloud dependencies for PHI processing.

Products by Carina AI

1 product in the directory

OncoAI Suite (BrainTumor AI)
Carina AI
Oncology AI
OncoAI Suite is an AI-native oncology imaging suite for cancer detection, segmentation, measurement, and longitudinal tracking across CT, MRI, and PET/CT. The BrainTumor AI module is currently in clinical use, providing volumetric tracking for glioma, brain metastasis, and vestibular schwannoma.

Reviews & Opinions

No web reviews on file yet for Carina AI. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Carina AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Carina AI →

View all on YouTube

Press & Coverage

Carina AI
Carina AI at SIIM 2026 u2014 Startup Kiosk 3
Carina AI will be showcasing live CuratAI demos and offering 30-minute slots with their clinical team at Startup Kiosk 3 during SIIM 2026 in Pittsburgh, from June 10u201312, 2026.
2026-06
Ronovo Surgical
Carinau2122 Makes History: NMPA Approves China's First Modular Robotic Platform for 4 Surgical Specialties!
Ronovo Surgical announced that its Carinau2122 Platform received NMPA regulatory approval for use in urologic, gynecologic, thoracic, and general surgery in China, marking a significant step in democratizing robotic surgery.
2025-03
The Robot Report
Ronovo Surgical's Carina robot gains $67M boost, J&J collaboration
Ronovo Surgical closed a $67 million Series D financing round, led by Johnson & Johnson's corporate venture capital organization, JJDC, for its Carina modular robotic surgery platform.
2025-09
Innovaccer Inc.
Carina Health & Innovaccer: Advancing Value-Based Care in CO
Carina Health Network partnered with Innovaccer to enhance value-based care for over 1.5 million Coloradans, leveraging AI-powered analytics and care management tools.
2026-03
Dealroom News
Ronovo Surgical raises $26M to commercialize Carina surgical robot | Dealroom News
Shanghai-based Ronovo Surgical raised $26 million in a Series B extension to accelerate the commercialization of its Carina robotic platform, which is designed for laparoscopy.
2026-07
Carina Software Group
Carina acquires Ikon Science, bolstering Geopredictive and Data Management capabilities
Carina Software announced the acquisition of Ikon Science, a global provider of geopredictive software, to enhance its geopredictive and data management capabilities.
2025-02
American Journal of Respiratory and Critical Care Medicine
Quantitative Computed Tomography in Progressive Pulmonary Fibrosis: Data from a Sub-Study of the Double Blind, Randomized, Placebo-controlled INBUILD Trial
This peer-reviewed article features research by Carina Ittrich and others on quantitative computed tomography in progressive pulmonary fibrosis, based on data from the INBUILD trial.
2026-09
PMC (PubMed Central)
Artificial Intelligence in Healthcare Practice: Validation, Fairness, and Regulatory Challenges: A Systematic Review - PMC
This systematic review discusses the validation, fairness, and regulatory challenges of artificial intelligence in healthcare practice, highlighting the need for stronger validation and implementation-focused research.
2026-08

Frequently Asked Questions

Carina AI offers several key products, including INTContour, an FDA-cleared AI auto-contouring platform for radiation oncology that supports over 120 organs-at-risk (OARs) across various imaging modalities. They also provide INTDose, an FDA-cleared independent Monte Carlo 3D secondary dose verification platform. For research, Carina AI has the OncoAI Suite for tumor detection and tracking, and QuantBrain for ventricle quantification.
Carina AI prioritizes data privacy and compliance through its on-premise architecture, ensuring no protected health information (PHI) leaves the institution's network. Their CuratAI platform offers pixel-level de-identification, including removing facial geometry while preserving intracranial anatomy, and semantic text de-identification from clinical notes and reports using a local Large Language Model (LLM). This approach aligns with HIPAA and IRB requirements, providing audit trails and keeping re-identification linking files within the institutional firewall.
Carina AI's INTContour provides FDA 510(k)-cleared AI auto-contouring with pre-loaded models for over 120 OARs. A key feature is the ability for institutions to train custom segmentation models on their own data, which has been shown to outperform vendor baselines on specific institutional protocols. For dose verification, INTDose offers independent Monte Carlo 3D secondary dose verification.
Yes, Carina AI's platforms are designed for integration. INTContour offers Eclipse TPS integration and supports automated DICOM workflows. CuratAI, their data curation platform, can pull data from PACS, EHR, and pathology systems, and ingest unstructured data into structured formats using a local LLM.
Carina AI provides technical consulting for optimizing AI tool development, including algorithm optimization, performance evaluation, and integration support. They also offer comprehensive support for FDA regulatory compliance, including 510(k) submission preparation. Carina AI partners with research groups, academic medical centers, and medical device companies, offering services like data curation, annotation, custom AI development, and regulatory pathway support.
Carina AI spun out of research labs at the University of Virginia and the University of Kentucky, founded by clinician-engineers. Their research has been supported by NIH SBIR awards, and they have multiple granted US patents and over 40 peer-reviewed publications. Carina Medical, founded in 2019, has raised funding over three rounds, including a grant in September 2022.
Carina AI's CuratAI platform is an on-premise, AI-native multimodal data curation platform for clinical research. It can retrieve data from various sources like PACS, EHR, and pathology systems, and process diverse modalities including DICOM, NIfTI, WSI, and PDFs. The platform also uses local LLMs to extract structured fields from unstructured clinical notes and reports, all while maintaining data privacy within the institutional firewall.

Related Companies

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]

Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.